Shukra Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
For the nine months, sales was INR 636.89 million compared to INR 125.88 million a year ago. Revenue was INR 651.27 million compared to INR 128.94 million a year ago. Net income was INR 145.51 million compared to INR 4.3 million a year ago. Basic earnings per share from continuing operations was INR 3.3225. Diluted earnings per share from continuing operations was INR 3.3225.